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Introduction
The internet has become a major tool 
to empower patients since it became freely 
accessible to the public in 1997. Accessing 
medical information is one of the most 
common reasons for people to use the web. In 
addition a new e-commerce market has been 
created which has revolutionized the public’s 
access to goods globally.¹
The internet pharmacy is a perfect 
example of the impact of increased access to 
healthcare goods offered by the newly created 
e-commerce market. Online pharmaceutical 
sales in the US alone, for example have grown 
from around 1% of the US pharmaceutical 
market to around 4% in 2007.  A prime and 
vulnerable patient population, the elderly, use 
it extensively in the US to shop for cheaper 
prescription medicines where savings of up to 
30% can be made.2 Many do so confident that 
their purchases offer the same quality and 
guarantees as those medicines bought in the 
pharmacy.7
The number of online pharmacies have 
expanded exponentially in the last 13yrs. 
Services and fees are often associated which 
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The internet has been a major revolution in enhancing the 
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well-established healthcare practices.  The Internet Pharmacy is 
now an integral part of these searches giving enhanced access to 
medicines to the public. It has become a global multibillion dollar 
market and brings with it threats and opportunities which could not 
have been foreseen. A Rogue Internet Pharmacy is a very real threat 
to the patient and healthcare professional. Of serious concern is 
the increase in distribution of counterfeit medicines through these 
sites. The EU is currently preparing legislation to regulate Internet 
Pharmacy Services to protect patients.
are not currently effectively regulated. Of 
concern are the cyberdoctor and the source of 
the medicines sold.¹,²
In Europe initial moves attempted 
to restrict or prohibit the movement of 
medicines between nations via online or 
Internet pharmacies. (DocMorris case: Case 
C-322/01 Deutcher Apothekerverband eV v 
0800 DocMorris NV – 11 December 2003)6  
European Union Treaties, Regulations and 
Directives have changed the capabilities of 
national professional associations to challenge 
the restrictions of internet sales of medicines 
within the Europe Union but not from third 
parties outside of the Union. European 
Union treaties provide a legal framework for 
e-commerce thereby providing the freedom 
of movement of medicines.5, 6 The variability 
regarding national legislation, licensing, 
pricing and reimbursement has rendered the 
applicability of this treaty more complex and 
open to legal challenge particularly regarding 
prescription only medicines.6
Patients wish to have access to cheaper 
medicines or medicines which are more 
difficult to obtain in their nation state 
because of the national legislation or simply 
because of lack of accessibility.
The Internet pharmacy offers them the 
possibility to do this across borders.¹, ², ³ 
This new enhanced accessibility presents 
serious challenges to well-established 
healthcare practice which contains benefits 
and threats. 10
Types of internet pharmacies 
and their services
Internet Pharmacies can be classified broadly 
into 4 types:¹
1. Extensions of pharmacy chains that offer 
a variety of online health information and 
products
2. Independent pharmacies, which often use 
the Internet to try to compete with larger 
chains
3. Mail-order pharmacies that use the 
Internet to facilitate the ordering process
4. Pharmacies that operate exclusively 
online.
Benefits associated with this service 
are linked with the ease, convenience and 
increased choice offered by a 24hr service 
open 7 days a week where comparisons can 
be made between a wide range of products. 
Increased access to consumer information 
and information exchange with the service 
provider which offers the potential for 
patients to enquire about their conditions 
and what therapeutic options maybe available 
to them. This is generally done anonymously 
and within a framework of privacy. Finally 
the financial savings can be considerable 
particularly in certain countries such as the 
United States.
Current concerns with 
the internet pharmacy
Currently a harmonized global regulation 
of these services does not exist. In the 
absence of appropriate harmonized laws, 
treaties and cooperative agreements between 
nation states, online sellers can evade 
regulation in certain jurisdiction by engaging 
in regulatory arbitrage (i.e. operating 
websites in a jurisdiction which has the least 
restrictive regulatory framework).
In many instances those evading 
regulation do so in order to engage in 
illegal activities. These are “Rogue Internet 
Pharmacies” which are involved in various 
illegal acts such as selling prescription 
drugs without a valid prescription, selling 
counterfeit or poor quality drugs, and 
providing online medical consultations 
(cyberdoctor) for prescribing and dispensing 
drugs. These “Rogue Internet Pharmacies” 
present a great danger to the public due to 
the potential harm, which can be caused by 
their illegal activities.
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Educational aims
•		To	create	awareness	amongst	health	care	professionals	of	benefits	and	risks	associated	
with the internet pharmacy
•		To	highlight	the	dangers	associated	with	purchasing	counterfeit	medicines	via	an	
internet pharmacy
•	 to	increase	healthcare	professionals	awareness	in	order	to	reduce	the	potential	risks	to	
public health.
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Challenge to traditional healthcare practice
With patients directly accessing online 
healthcare services like the Internet Pharmacy 
the traditional safeguards assured by the 
patients physician and the dispensing 
pharmacist are by-passed. The patient as a 
result confides anonymously to a cyberdoctor 
who often does not know the patients current 
condition (in some cases this is just a 
questionnaire service which directs a patient 
to a treatment also offered by the online 
pharmacy). As a consequence the patient is 
no longer protected and becomes a consumer 
who is exposed to services whose aim is not 
to a service in the interests of public health 
but to obtain financial gain.6
The cyberdoctor is troubling in that 
the patient-doctor/patient-pharmacist 
relationship is threatened but when linked to 
the distribution of prescription only medicines 
this can be extremely harmful.4,5,6 In 
particular the risk of counterfeit medicines is 
perhaps the greatest.5,6, Counterfeit medicines 
have progressively infiltrated the distribution 
chain through the Internet pharmacy.7,9 Many 
medicines are now manufactured in areas 
outside the traditional sites in the Developed 
World. Regulatory control is less effective 
and the quality of medicines more variable 
with counterfeit medicines being the worst 
end product of a now weakened system of 
quality control. Online pharmacies are often 
difficult to trace making the establishment of 
the Rogue Internet Pharmacy easier.9,10 These 
sites often work from an unregulated site, 
have no address, are registered in China and 
hosted in Russia. The WHO estimates that 
50% of medicines available to consumers from 
Internet sites which conceal their physical 
address are counterfeit. The internet offers 
them the possibility to target the wealthiest 
markets where connectivity is greatest; 
Europe and North America. This represents 
a direct challenge to traditional pharmacies 
which dispense and ensure the quality of 
prescription only medicines.
In the UK over the last few years there 
have been several serious cases of these sites 
distributing these drugs within the country 
or using the country as a warehousing transit 
point for other markets for example in the 
North America. Originally, these involved life 
style drugs but recently these have started 
to include life-saving drugs. Some of the 
high profile cases are reported on the UK 
MHRA (Medicines and Healthcare Products 
Regulatory Agency) website.10 
Current actions to address the threat
Governments Agencies are increasingly 
installing surveillance systems to monitor for 
the presence of Rogue Online Pharmacies. 
With these systems for example the MHRA 
recently conducted a large operation to seize 
counterfeit drugs distributed through Internet 
Pharmacies. These approaches however are 
not preventative. 
In the US the FDA has made efforts to 
set up a system of accreditation of these 
services so that consumer and healthcare 
workers can be protected and be guaranteed 
that a regulatory framework is in place to 
ensure that the quality of the service is to an 
adequate standard.
In the EU efforts are current on-going 
to draft and approve legislation which will 
effectively regulate and clarify the penalties 
imposed on those in breech of the new 
legislation (Euractiv 28 April 2010 Parliament 
takes aim at illegal online pharmacies). 
Indeed in July 2010 the European Parliament 
will have a plenary session to discuss the 
Falsified Medicines Directive.8
Conclusion
The advent of the internet and its 
enhanced accessibility has opened a new 
era of e-commerce which offers benefits and 
risks. The Internet Pharmacy is a case in 
point. The services are often but not always 
associated with a credible wholesale source of 
pharmaceutical products.
With the development of the global 
internet the accessibility of markets from 
different parts of the globe has led to a 
situation of regulatory arbitrage. This means 
that certain countries have weaker regulatory 
frameworks from which Rogue Internet 
Pharmacies can operate and access with 
impunity the richer markets of Europe and 
North America or distribute cheap counterfeit 
medications to poor countries. This leads to 
a breakdown in the traditional mechanisms 
of regulation of healthcare services involved 
in the dispensing of prescription medicines 
where there is a relationship between 
patient, physician and pharmacist. The 
patient becomes a consumer and is no longer 
protected by the healthcare professionals who 
are often not aware of their purchases on the 
internet. 
Efforts are currently on going in the 
European Parliament to endorse a new EU 
Directive to improve the regulation of this 
online service and penalize rogue internet 
pharmacies.
Key points
•		 Various	types	of	internet	pharmacies	exist,	not	all	of	which	are	engaged	in	illegal	
activity
•			Rogue	Internet	Pharmacies	involved	in	illegal	activities	e.g.	selling	prescription	drugs	
without a valid prescription, selling counterfeit or poor quality drugs, and providing 
online medical consultations (cyberdoctor) for prescribing and dispensing drugs
•	 Online	pharmacies	are	often	difficult	to	trace	making	the	establishment	of	the	Rogue	
Internet Pharmacy easier
•	 WHO	estimates	that	in	over	50%	of	cases,	medicines	purchased	over	the	Internet	from	
illegal sites that conceal their physical address are counterfeit
•	 EU	working	on	legislation	to	combat	counterfeit	medicines
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